FIELD: pharmaceutics.
SUBSTANCE: invention relates to compounds represented by formulas (I)-(XXII) or pharmaceutically acceptable salts thereof:
. Invention also relates to a pharmaceutical composition having an inhibiting effect with respect to the receptor α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) on the basis of said compounds.
EFFECT: technical result consists in producing novel compounds and a pharmaceutical composition on the basis of said compounds, which can be used in medicine for treating epilepsy.
16 cl, 4 tbl, 2 dwg, 22 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BROMDOMAIN INHIBITORS | 2012 |
|
RU2671571C1 |
| BICYCLIC 6-ALKYLIDENEPENEMS AS β-LACTAMASE INHIBITORS | 2003 |
|
RU2339640C2 |
| BROMDOMAIN INHIBITORS | 2012 |
|
RU2647592C2 |
| MACROCYCLIZATION REACTIONS AND INTERMEDIATE COMPOUNDS AND OTHER FRAGMENTS SUITABLE FOR PREPARING ANALOGUES OF HALICHONDRIN B | 2014 |
|
RU2710545C2 |
| DERIVATIVES OF 5,6-DIHYDROPYRONE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1994 |
|
RU2140917C1 |
| PRINCE REACTION AND INTERMEDIATE PRODUCTS USED IN SYNTHESIS OF HALICHONDRIN MACROLIDES AND THEIR ANALOGUES | 2017 |
|
RU2777913C2 |
| BROMODOMAIN INHIBITORS | 2017 |
|
RU2741808C2 |
| TRICYCLIC HETEROCYCLIC COMPOUNDS AND JAK INHIBITORS | 2012 |
|
RU2632870C2 |
| DISPIROPYRROLIDINE DERIVATIVES | 2012 |
|
RU2612534C2 |
| PIRAZOLOQINOLINE DERIVATIVE | 2012 |
|
RU2605096C2 |
